These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review. Gambrell RD; Bagnell CA; Greenblatt RB Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050 [TBL] [Abstract][Full Text] [Related]
4. The epidemiology of endometrial cancer in young women. Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544 [TBL] [Abstract][Full Text] [Related]
5. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Key TJ; Pike MC Br J Cancer; 1988 Feb; 57(2):205-12. PubMed ID: 3358913 [TBL] [Abstract][Full Text] [Related]
6. Ovarian and endometrial cancers. Mant JW; Vessey MP Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220 [TBL] [Abstract][Full Text] [Related]
7. A case-control study of cancer of the endometrium. Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042 [TBL] [Abstract][Full Text] [Related]
8. Update on cancer control in women. Boyle P; Maisonneuve P; Autier P Int J Gynaecol Obstet; 2000 Aug; 70(2):263-303. PubMed ID: 10960611 [TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives and neoplasia of the uterine corpus. Schlesselman JJ Contraception; 1991 Jun; 43(6):557-79. PubMed ID: 1868733 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for endometrial cancer. Ali AT Ceska Gynekol; 2013 Nov; 78(5):448-59. PubMed ID: 24313431 [TBL] [Abstract][Full Text] [Related]
11. The epidemiology of ovarian cancer. Parazzini F; Franceschi S; La Vecchia C; Fasoli M Gynecol Oncol; 1991 Oct; 43(1):9-23. PubMed ID: 1959794 [TBL] [Abstract][Full Text] [Related]
12. [Recent progress in epidemiologic research of uterine cancer]. Mori M; Sagae S Gan To Kagaku Ryoho; 2001 Feb; 28(2):174-8. PubMed ID: 11242642 [TBL] [Abstract][Full Text] [Related]
13. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus. Schwartz SM; Weiss NS; Daling JR; Gammon MD; Liff JM; Watt J; Lynch CF; Newcomb PA; Armstrong BK; Thompson WD Cancer; 1996 Feb; 77(4):717-24. PubMed ID: 8616764 [TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of oral contraceptive use. Williams RS Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913 [TBL] [Abstract][Full Text] [Related]
16. Incidence of endometrial cancer in relation to the use of oral contraceptives. Weiss NS; Sayvetz TA N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890 [TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and endometrial cancer: do other risk factors modify the association? Stanford JL; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Hoover RN Int J Cancer; 1993 May; 54(2):243-8. PubMed ID: 8486426 [TBL] [Abstract][Full Text] [Related]
18. The prevention of breast cancer through reduced ovarian steroid exposure. Spicer DV; Pike MC Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631 [TBL] [Abstract][Full Text] [Related]
19. A population-based case-control study of endometrial cancer in Shanghai, China. Shu XO; Brinton LA; Zheng W; Gao YT; Fan J; Fraumeni JF Int J Cancer; 1991 Aug; 49(1):38-43. PubMed ID: 1874568 [TBL] [Abstract][Full Text] [Related]
20. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use. Petitti DB; Porterfield D Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]